Patent 9266893 was granted and assigned to Pharmacyclics on February, 2016 by the United States Patent and Trademark Office.
Disclosed herein is a solid oral dosage form comprising at least one coating chosen from enteric coatings and delayed release coatings, at least one pharmaceutically acceptable excipient, and a compound, or a pharmaceutically acceptable salt thereof, having the structure: